Giardiasis
📧 Sign up to get email alerts when something new happens for Giardiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-13FDA Approved: METRONIDAZOLE — Original Application (Viona Pharmaceuticals Inc)
FDA approved the original ANDA for metronidazole from Viona Pharmaceuticals Inc, enabling a generic version of the antibiotic to be marketed…
-
FDA approval · 2025-02-14FDA Approved: METRONIDAZOLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for metronidazole from Alembic Pharmaceuticals Limited.
-
FDA approval · 2025-02-03FDA Approved: NITAZOXANIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for nitazoxanide, a generic treatment for infections caused by Giardia lamblia and Cr…
-
FDA approval · 2024-12-17FDA Approved: METRONIDAZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Metronidazole from Sun Pharmaceutical Industries, Inc., resulting in continued approval of this …
-
FDA approval · 2024-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Metronidazole filed by Aurobindo Pharma Limited, authorizing the generic product under the suppl…
-
FDA approval · 2024-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Metronidazole from Alembic Pharmaceuticals Limited, confirming continued approval of the generic…
-
FDA approval · 2024-09-04FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.
-
FDA approval · 2024-06-18FDA Approved: METRONIDAZOLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Metronidazole from Alembic Pharmaceuticals Limited, granting approval for a generic version of t…
-
FDA approval · 2024-06-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.) to modify…
-
FDA approval · 2024-01-09FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Metronidazole from Aurobindo Pharma Limited.
-
FDA approval · 2023-10-17FDA Approved: METRONIDAZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Metronidazole filed by Sun Pharmaceutical Industries, Inc., updating the drug’s labeling as …
-
FDA approval · 2023-09-12FDA Approved: TINDAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for TINDAZOLE (tinidazole) from Rising Pharma Holdings, Inc., granting additional regulatory authori…
-
FDA approval · 2023-07-12FDA Approved: METRONIDAZOLE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals, Inc.'s original application for a generic metronidazole.
-
FDA approval · 2023-04-21FDA Approved: METRONIDAZOLE — Original Application (Viona Pharmaceuticals Inc)
The FDA approved Viona Pharmaceuticals' original application for metronidazole, granting a generic version of the antibiotic/antiprotozoal.
-
FDA approval · 2022-08-11FDA Approved: NITAZOXANIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for nitazoxanide submitted by Rising Pharma Holdings, Inc. (Nitazoxanide).
-
FDA approval · 2022-07-25FDA Approved: TINIDAZOLE — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for Tinidazole from Edenbridge Pharmaceuticals LLC., confirming regulatory approval of a generic Tin…
-
FDA approval · 2022-03-31FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metronidazole from Aurobindo Pharma Limited, indicating a supplemental approval for this generic…
-
FDA approval · 2022-03-16FDA Approved: METRONIDAZOLE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for METRONIDAZOLE submitted by Prasco Laboratories.
-
FDA approval · 2021-12-15FDA Approved: TINDAMAX — Supplemental Application (Mission Pharmacal Company)
FDA approved a supplemental application for TINDAMAX (tinidazole) from Mission Pharmacal Company.
-
FDA approval · 2021-10-14FDA Approved: METRONIDAZOLE — Original Application (Solaris Pharma Corporation)
FDA approved Solaris Pharma Corporation's generic metronidazole (METRONIDAZOLE) under an original ANDA.
-
FDA approval · 2021-09-03FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for Metronidazole, enabling a generic version of the antibiotic/antiprotozoal.
-
FDA approval · 2021-08-19FDA Approved: METRONIDAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for METRONIDAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., signaling an approved change…
-
FDA approval · 2021-08-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Metronidazole from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2021-03-05FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Metronidazole submitted by Baxter Healthcare Corporation.